Mise à jour : Paris FC et Vinci lancent un nouveau programme pour les jeunes de l’Académie
PARIS FC et VINCI annoncent un nouveau programme pour les jeunes de l'Académie
Update: Kuehne+Nagel And Medtronic Open Healthcare Centre In Milton, Canada
Kuehne+Nagel and Medtronic open a temperature-controlled healthcare fulfilment centre in Milton, Canada, supporting medical device distribution and maintenance.
Update: Paris FC, Vinci Launch New Program For Academy Youths
PARIS FC and VINCI announce a new program for PARIS FC Academy Youths. VINCI processes data for press release subscriptions. To unsubscribe or…
Coca-Cola, Bacardi Launch New Bacardí & Coca-Cola Ready-To-Drink Cocktail
The Coca-Cola Company and Bacardi Limited will launch BACARDÍ & Coca-Cola Ready-To-Drink Cocktail.
Salesforce Unveiled AI Innovations At Dreamforce
TLDR: Salesforce announced innovations at Dreamforce, including Agentforce AI agents, Data Cloud updates, a new Slack interface, and the first Agent Ecosystem. Salesforce…
Stellantis Pro One Opens A Global Commercial Vehicles Hub In Turin, Enhancing Efficiency
Stellantis Pro One opens global commercial vehicles hub in Turin, Italy, emphasizing commitment to business customers, efficiency, and decision-making. Stellantis CEO, Carlos Tavares,…
Update: Unilever and UNFCCC Urge Business-Government Collaboration For Quicker Emission Cuts ahead of UN’s General Assembly in NYC
Unilever discusses the importance of collaboration between businesses and governments to combat climate change. CEO Hein Schumacher and former UNFCCC Executive Secretary Patricia…
آئی ایچ جی ہوٹلز اینڈ ریزورٹس نے پاکستان میں اسلام آباد میں ایک نی ہالیڈے اِن اینڈ سوئٹس متعارف کرانے کے ساتھ اپنی توسیع کا اعلان کیا ہے، جو اگست 2028 میں کھلنے کے لیے تیار ہے۔
منگل، 17 ستمبر 2024، 10:17:22 یو ٹی سی— آئی ایچ جی ہوٹلز اینڈ ریزورٹس نے پاکستان میں ایک اہم توسیع کا اعلان کیا…
Update: IHG To Open Holiday Inn & Suites In Islamabad By August 2028
IHG Hotels & Resorts expands into Pakistan with a new Holiday Inn & Suites in Islamabad. The company has a global presence with…
Update: Merck’s Patritumab Deruxtecan Outperforms Doublet Chemotherapy
Merck & Co. announced that Patritumab Deruxtecan showed significant progress in patients with advanced EGFR-mutated lung cancer in a Phase 3 trial. For…